Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Amisulpride Oral Solution

Approval Number

国药准字H20244722

Company广州大光制药有限公司

Registration Date

August 27, 2024

Drug Information

Generic Name

氨磺必利口服溶液

Dosage Form

口服溶液剂

Strength

60ml∶6g

Drug Type

化学药品

Registration Date

August 27, 2024

Company Information

Applicant Company

Company Name广州大光制药有限公司

Company Address

广州市黄埔区瑞泰路7号自编一、二、三、五栋

Manufacturing Company

Company Name华益药业科技（安徽）有限公司

Company Address

合肥市包河区工业区上海路11号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

氨磺必利口服溶液 - NMPA 批准文号 | MedPath